产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

1584645-37-3

英文名称

-

别名

Rozanolixizumab;Research Grade Rozanolixizumab(DHF14602);UCB7665;UCB-7665;Research Grade Rozanolixizumab;Rozanolixizumab (anti-FCGRT)

用途

Rozanolixizumab is being developed for the treatment of various IgG autoantibody-driven autoimmune diseases by promoting the clearance of pathogenic IgG autoantibodies. Its intended therapeutic indications include generalized myasthenia gravis (gMG), primary immune thrombocytopenia (ITP), myelin oligodendrocyte glycoprotein immunoglobulin G antibody-associated disease (MOGAD), autoimmune encephalitis (AIE), and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).

安全信息

评论 0
我是晶智Agent,
您的化学小助手